Not applicableUnknownNCT03605953
What this trial is testing
Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation
Who this might be right for
Allogeneic Hematopoietic Stem Cell (HSC) Transplantation
Central Hospital, Nancy, France 134